Related Experiment Video
Updated: Jan 19, 2026

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
Published on: September 20, 2018
Pediatric Behçet's disease - clinical aspects and current concepts
Mehmet Yıldız1, Oya Köker2, Amra Adrovic1
1Department of Pediatric Rheumatology, İstanbul University-Cerrahpaşa, Cerrahpaşa School of Medicine, İstanbul, Turkey.
Pediatric Behçet's Disease (pBD) is a rare multisystemic disorder with unclear etiology and diagnostic challenges. Current research focuses on understanding its complexities and developing new therapeutic options.
Area of Science:
- Rheumatology
- Immunology
- Genetics
Background:
- Behçet's Disease (BD) was initially described as a triad of aphthous stomatitis, genital ulcers, and uveitis.
- Current understanding recognizes BD as a multisystemic, recurrent inflammatory condition with significant morbidity and mortality.
- Pediatric Behçet's Disease (pBD) presents unique diagnostic and management challenges due to its rarity in childhood.
Purpose of the Study:
- To highlight the current knowledge gaps and challenges in diagnosing and managing Pediatric Behçet's Disease.
- To emphasize the need for further research into the etiologic mechanisms of pBD.
- To discuss the potential of emerging therapeutic strategies.
Main Methods:
- Review of existing literature on Behçet's Disease, with a focus on pediatric cases.
- Analysis of current diagnostic criteria and their limitations in pediatric populations.
- Exploration of immunological and genetic associations.
Main Results:
- The exact etiologic mechanism of Behçet's Disease remains unclear despite identified immunological and genetic links.
- Diagnostic criteria validated in adults are often inadequate for pediatric cases, complicating diagnosis.
- The geographic distribution of clinical manifestations adds complexity to disease management.
Conclusions:
- Pediatric Behçet's Disease requires further investigation due to diagnostic difficulties and unclear etiology.
- Development of validated pediatric-specific diagnostic criteria is crucial.
- Promising new therapeutic options are emerging based on pathogenetic hypotheses.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Pharmacokinetics in Pediatric Patients: Drug Distribution
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

